Our manufacturing capacity grows with your needs. When you're ready to scale up, we deliver consistent quality at higher volumes.
https://www.lannettcdmo.com/
Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031.
As such, oral solid dose (OSD) formulations are poised to gain significant traction.
This shift demands manufacturing partners with proven expertise in:
💊Specialized potent compound handling
⏳ Modified release technology
🎯 Precise quality control systems
📈 Continuity of supply
https://www.lannettcdmo.com/ad....vanced-formulation-a
We offer adaptable manufacturing options to accommodate varying production scales and timelines for our partners.
Contact us to find out more-
https://www.lannettcdmo.com/ph....armaceutical-manufac
The Evolution of Pharmaceutical Manufacturing: Trends and Innovations
https://pharmacontractor.blogs....pot.com/2025/01/the-
Lannett CDMO: Pharmaceutical Contract Manufacturing Partner Lannett is a leading pharmaceutical contract manufacturer that has been partnering with clients of unique NDA products for 75 years.
